-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
PUMA BIOTECHNOLOGY, INC. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2012 to Q4 2024.
- PUMA BIOTECHNOLOGY, INC. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2024 was -$7.07M, a 1418% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2024 was -$6.18M, a 670% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. annual Income Tax Expense (Benefit) for 2024 was -$6.18M, a 670% decline from 2023.
- PUMA BIOTECHNOLOGY, INC. annual Income Tax Expense (Benefit) for 2023 was $1.08M, a 138% increase from 2022.
- PUMA BIOTECHNOLOGY, INC. annual Income Tax Expense (Benefit) for 2022 was $455K, a 40.4% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)